127 related articles for article (PubMed ID: 1878718)
1. Hepatic veno-occlusive disease following bone marrow transplantation treated by prostaglandin E1.
Ibrahim A; Pico JL; Maraninchi D; Zambon E; Attal M; Brault P; Tilly H; Blaise D; Hayat M
Bone Marrow Transplant; 1991; 7 Suppl 2():53. PubMed ID: 1878718
[No Abstract] [Full Text] [Related]
2. [A trial use of prostaglandin E1 for prevention of hepatic veno-occlusive disease after allogeneic bone marrow transplantation].
Morio S; Oh H; Kogure K; Ishii H; Ishii A; Nakaseko C; Ikegami T; Kawano E; Matsuura Y; Nishimura M
Rinsho Ketsueki; 1994 Sep; 35(9):846-52. PubMed ID: 7967053
[TBL] [Abstract][Full Text] [Related]
3. Role of PGE1 to prevent veno-occlusive disease of the liver after bone marrow transplantation.
Gluckman E; Jolivet I; Scrobohaci ML; Devergie A; Traineau R; Bourdeau-Espérou H; Lehn P; Faure P; Drouet L
Nouv Rev Fr Hematol (1978); 1990; 32(1):1-3. PubMed ID: 2349075
[TBL] [Abstract][Full Text] [Related]
4. No beneficial effects, but severe side effects caused by recombinant human tissue plasminogen activator for treatment of hepatic veno-occlusive disease after allogeneic bone marrow transplantation.
Hägglund H; Ringdén O; Ljungman P; Winiarski J; Ericzon B; Tydén G
Transplant Proc; 1995 Dec; 27(6):3535. PubMed ID: 8540088
[No Abstract] [Full Text] [Related]
5. Successful treatment with recombinant soluble thrombomodulin of two cases of sinusoidal obstructive syndrome/hepatic veno-occlusive disease after bone marrow transplantation.
Ohwada C; Takeuchi M; Kawaguchi T; Tsukamoto S; Sakai S; Takeda Y; Abe D; Sakaida E; Shimizu N; Yokote K; Iseki T; Nakaseko C
Am J Hematol; 2011 Oct; 86(10):886-8. PubMed ID: 21818767
[No Abstract] [Full Text] [Related]
6. Management of hepatic veno-occlusive disease (VOD) in pediatric patients: retrospective analysis in 6 AIEOP-BMT (Italian Pediatric Hematology Oncology Association-Bone Marrow Transplantation Group) Centers.
Miniero R; Vassallo E; Soldano S; Nesi F; Vai S; Balduzzi A; Varotto S; Dallorso S; Prete A; Arcese W
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():157-9. PubMed ID: 8932820
[No Abstract] [Full Text] [Related]
7. Successful treatment of an infant with veno-occlusive disease developed after allogeneic bone marrow transplantation by tissue plasminogen activator, heparin and prostaglandin E1.
Higashigawa M; Watanabe M; Nishihara H; Tabata N; Azuma E; Ido M; Ito M; Sakurai M
Leuk Res; 1995 Jul; 19(7):477-80. PubMed ID: 7637394
[TBL] [Abstract][Full Text] [Related]
8. [The treatment with prostaglandin E1 of a suspected hepatic veno-occlusive disease in a leukemic patient].
Sculier JP; Bron D
Rev Med Brux; 1988 Oct; 9(7-8):398-400. PubMed ID: 3187257
[No Abstract] [Full Text] [Related]
9. Veno-occlusive disease of the liver complicating ABMT successfully treated with recombinant tissue plasminogen activator (rt-PA).
Baglin TP; Harper P; Marcus RE
Bone Marrow Transplant; 1990 Jun; 5(6):439-41. PubMed ID: 2369685
[TBL] [Abstract][Full Text] [Related]
10. Veno-occlusive disease of the liver complicating bone marrow transplantation.
Baglin TP
Bone Marrow Transplant; 1994 Jan; 13(1):1-4. PubMed ID: 8019444
[TBL] [Abstract][Full Text] [Related]
11. Hepatic veno-occlusive disease following bone marrow transplantation.
Grandt NC
Oncol Nurs Forum; 1989; 16(6):813-7. PubMed ID: 2687804
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of hepatic veno-occlusive disease after bone marrow transplantation with recombinant human tissue plasminogen activator (rh-tPA)].
Yoshimi A; Kato K; Maeda N; Matsuyama T; Kojima S
Rinsho Ketsueki; 2000 Feb; 41(2):103-8. PubMed ID: 10723238
[TBL] [Abstract][Full Text] [Related]
13. The prothrombin gene variant G20210A but not factor V leiden may be associated with veno-occlusive disease following BMT.
Duggan C; Schmidt M; Lawler M; White B; Cusack S; McCann S; Smith O
Bone Marrow Transplant; 1999 Sep; 24(6):693-4. PubMed ID: 10490739
[No Abstract] [Full Text] [Related]
14. [Percutaneous intrahepatic portosystemic shunting in the treatment of veno-occlusive disease of the liver after bone marrow transplantation].
Alvarez R; Bañares R; Casariego J; Echenagusía A; Simó G; Alvarez E; Serrano D; Díez-Martín JL
Gastroenterol Hepatol; 2000 Apr; 23(4):177-80. PubMed ID: 10863859
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institution.
Kami M; Mori S; Tanikawa S; Akiyama H; Onozawa Y; Tanaka T; Okamoto R; Maeda Y; Sasaki T; Kaku H; Matsuura Y; Hiruma K; Sakamaki H
Bone Marrow Transplant; 1997 Sep; 20(5):397-402. PubMed ID: 9339756
[TBL] [Abstract][Full Text] [Related]
16. [Veno-occlusive disease after bone marrow transplantation: preventive effect of heparin].
Parquet N; Devergie A; Socié G; Ribaud P; Espérou H; Gluckman E
Ann Med Interne (Paris); 1997; 148(2):132-5. PubMed ID: 9238437
[TBL] [Abstract][Full Text] [Related]
17. Hepatic veno-occlusive disease following peripheral blood stem cell or bone marrow transplantation.
Salat C; Holler E; Hiller E; Pihusch R; Kolb HJ
Haematologica; 1999 Jun; 84 Suppl EHA-4():40-3. PubMed ID: 10907464
[No Abstract] [Full Text] [Related]
18. Fatal hemorrhage after recombinant tissue plasminogen activator therapy for hepatic veno-occlusive disease complicating autologous BMT.
Otheo de Tejada E; Maldonado MS; Camarero C; Muñoz A
Bone Marrow Transplant; 1994 Jul; 14(1):176-7. PubMed ID: 7951113
[No Abstract] [Full Text] [Related]
19. A review of tissue plasminogen activator in the treatment of veno-occlusive liver disease after bone marrow transplantation.
Terra SG; Spitzer TR; Tsunoda SM
Pharmacotherapy; 1997; 17(5):929-37. PubMed ID: 9324182
[TBL] [Abstract][Full Text] [Related]
20. [Veno-occlusive disease of the liver after bone marrow transplantation. Report of the symposium Autograft in France and the group of study of bone marrow transplantation. France Auto-Greffe et le Groupe d'Etude de la Greffe de Moelle osseuse].
Rio B; Cahn JY; Attal M; Drouet L; Scrobohaci ML; Degos F; Degott C; Bearman SI; Grañena A; Blaise D
Presse Med; 1994 Sep 3-10; 23(26):1217-22. PubMed ID: 7831216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
